Previous Article | Next Article ![]()
Journal of Virology, September 2004, p. 10193-10196, Vol. 78, No. 18
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.18.10193-10196.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
134.5 Gene Products
Department of Microbiology and NYU Cancer Institute, New York University School of Medicine, New York, New York 10016
Received 3 February 2004/ Accepted 26 April 2004
The
134.5 gene product is important for the resistance of herpes simplex virus type 1 (HSV-1) to interferon. However, since the inhibition of protein synthesis observed in cells infected with a
134.5 mutant virus results from the combined loss of the
134.5 gene product and the failure to translate the late Us11 mRNA, we sought to characterize the relative interferon sensitivity of mutants unable to produce either the Us11 or the
134.5 polypeptide. We now demonstrate that primary human cells infected with a Us11 mutant virus are hypersensitive to alpha interferon, arresting translation upon entry into the late phase of the viral life cycle. Furthermore, immediate-early expression of Us11 by a
134.5 deletion mutant is sufficient to render translation resistant to alpha interferon. Finally, we establish that the Us11 gene product is required for wild-type levels of replication in alpha interferon-treated cells and, along with the
134.5 gene, is an HSV-1-encoded interferon resistance determinant.
For Bernard Roizman, il miglior fabbro, on the occasion of his 75th year.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|